Repair of periodontal furcation defects in beagle dogs following reconstructive surgery including root surface demineralization with tetracycline hydrochloride and topical fibronectin application.
This study examines the effects of root surface demineralization and topical fibronectin as adjuncts to reconstructive periodontal surgery. In 14 beagle dogs, horizontal periodontal defects were surgically induced around the mandibular premolars followed by a 6-week period without plaque control. Reconstructive surgery of the defects was subsequently carried out. The root surfaces were debrided and superficially demineralized with citric acid or tetracycline hydrochloride, with or without subsequent application of fibronectin. Mucoperiosteal flaps were raised to cover most of the crowns and sutured. The animals were sacrificed 12 weeks after surgery and block sections of the teeth and surrounding tissues were processed for histology. Analysis included incidence of furcation defects presenting with an epithelial lining, quantification of connective tissue repair relative to the furcation circumference, and regeneration of alveolar bone relative to the furcation defect height. The incidence of root resorption and ankylosis was also analyzed. Within the limitations of this study it was concluded that: (1) citric acid conditioning of the root surface frequently resulted in complete connective tissue repair of the furcation defect; (2) root resorption and ankylosis were prevalent features of the healing response; (3) citric acid and tetracycline treatment had similar potential to induce connective tissue repair and resulted in corresponding incidences of root resorption and ankylosis; (4) application of fibronectin to demineralized root surfaces did not enhance the amount of connective tissue repair and did not alter the pattern of root resorption and ankylosis.
School of Dental Medicine, State University, New York, Buffalo.
U M
UM
Wikesjö
N
N
Claffey
L A
LA
Christersson
L C
LC
Franzetti
R J
RJ
Genco
V P
VP
Terranova
J
J
Egelberg
D000287:Administration, Topical; D000539:Alveolar Process / Q000473:pathology; D000818:Animals; D001641:Bicuspid; D002951:Citrates / Q000008:administration & dosage / Q000627:therapeutic use; D019343:Citric Acid; D004285:Dogs; D005353:Fibronectins / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D010510:Periodontal Diseases / Q000601:surgery*; D010519:Periodontium / Q000473:pathology; D013524:Surgical Flaps; D013752:Tetracycline / Q000008:administration & dosage / Q000627:therapeutic use*; D014092:Tooth Root / Q000187:drug effects / Q000473:pathology
D002951:Citrates; D005353:Fibronectins; D019343:Citric Acid; D013752:Tetracycline